SEC Form 4 · accession 0001393905-18-000003
Biohaven Pharmaceutical Holding Co Ltd. · BHVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
PORTAGE BIOTECH INC.
10% Owner
Period of report
Jan 3, 2018
Accepted (ET)
Jan 5, 2018 · 10:29 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001689813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 4, 2018 | S | 4,350 | $28.6217 | D | 124,371 | D |
Table II — derivative securities
No Table II lines on this filing.